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Activity-based probes are small molecules that can be used tomonitor enzyme activity by covalently binding
to specific residues in the active site. In this issue of Chemistry & Biology, Lu and colleagues developed
a specific fluorescent activity-based probe that targets the papain-like cysteine bacterial type III effector
protease AvrPphB and used it to demonstrate the regulation of the protease secretion and pathogenesis.Proteases are significant factors in all
species and are involved in numerous
regulatory processes. Over the last few
decades, advancements in gene and
protein expression analysis have led to a
better understanding of protease activity
and their effect on cellular dynamics.
Importantly, unlike other cell signaling
processes, cleavage by a protease is an
irreversible process; therefore, protease
activity is tightly regulated posttransla- Activity Based Probe
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Figure 1. ABP Methodology and AvrPphB Mechanism of Action
(A) ABP and binding mechanism. The general structure of an ABP with an
AOMK-reactive moiety. Schematic activity-dependent labeling of a cysteine
protease target by an ABP. Covalent modification of the target protease leads
to a fluorescently labeled enzyme.
(B) Labeling of AvrPphB by FH11. FH11 binds to AvrPphB containing a
pro-domain in bacteria. AvrPphB translocates from the bacteria (blue) to the
plant host (green) with the pro-domain attached. Upon entrance into the
host, the pro-domain is cleaved, and AvrPphB triggers hypersensitivity cell
death response.tionally. Proteases are gener-
ated as inactive zymogens
that require activation by
removal of an inhibitory pro-
domain. In addition, prote-
ases can be bound to endog-
enous inhibitors or require
translocation to cleave their
substrates (Turk, 2006). In
recent years, small molecule
activity-based probes (ABPs)
have emerged as useful tools
to study protease function,
because these probes specif-
ically bind the active enzyme
(Fonovic and Bogyo, 2007).
ABPs have been developed
to allow for biochemical
studies of active proteases
and to image their location in
cells, tissue, and whole or-
ganisms (Blum, 2008). These
tools have dramatically en-
hanced our ability to investi-
gate protease function in
pathological processes.
In the case of plants, the
molecular mechanisms by
which pathogens trigger dis-
ease are poorly understood.
In this issue of Chemistry
and Biology, Lu et al. (2013)
elegantly describe the use of
a fluorescent ABP to investi-gate the function and secretion of the
plant pathogen Pseudomonas syringae
cysteine protease, a type III effector
AvrPphB that is known to enter the host
plant cell and can cause the hypersensi-
tive cell death response (HR) (Shao
et al., 2003).
Lu et al. (2013) analyzed AvrPphB
substrate and auto cleavage sites to pro-
duce the ABP FH11, a rhodamine-labeled
tri-peptide acyloxymethyl ketone. UsingChemistry & Biology 20, February 21, 2013an alanine scan of AvrPphB’s substrate
cleavage sites, they determined the
amino acid sequence crucial for protease
recognition and cleavage. They then
synthesized an ABP by constructing a
short tri-peptide sequence, Gly-Asp-Ala,
and converting the carboxy terminus to
the reactive moiety acyloxymethylke-
tone (AOMK), which enables covalent
attachment to the cysteine active site
upon protease activity. The fluorophoreª2013 Elserhodamine was attached to
the amino terminal, creating
the full probe. Therefore,
when the activated protease
AvrPphB binds the FH11
probe, a covalent bond is
created by the AOMK, gener-
ating a fluorescent adduct to
the protein that allows for
sophisticated biochemical
analysis (Figure 1A). In this
work, Lu et al. (2013) used
a small library of substrates
to identify the preferred se-
quence for generating the
ABP. Notably, the authors
inserted aspartic acid at the
P2, an unusual sequence for
papain-like enzymes, thereby
enhancing the specificity of
the probe. While several re-
ported approaches for se-
quence identification exist,
such as phage display and
synthetic methods using
positional scanning combina-
torial libraries (Backes et al.,
2000), generating specific
ABPs that target a single pro-
tease, as reported by Lu et al.
(2013), remains challenging.
The authors applied FH11
to investigate the correct
folding and involvement ofvier Ltd All rights reserved 137
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Previewsthe AvrPphB prodomain in its secretion
process, the cellular location of pro-
domain removal, and how the prodo-
main removal effects protease activity.
AvrPphB is a 3.3 nm 35 kDa pro-protease
that is known to autocatalytically cleave to
a 28 kDa isoform. Previous work has
shown that the protease is injected into
the host cell through a type III secretion
system (TTSS), after which the protein is
targeted to the host membrane and
cleaves host kinases (Nimchuk et al.,
2000; Dowen et al., 2009). A major ques-
tion in the regulation of this process is if
the cleavage of the AvrPphB prodomain
occurs in the bacteria or in the host cell.
It is widely assumed that the cleavage
must occur in the bacteria, because the
type III pilus is estimated at a width
smaller than 2.5 nm, which is likely too
small for the full AvrPphB to traverse. To
answer this fundamental question, the
authors made use of both biological and
chemical methodologies. First, using
FH11, they found that AvrPphb secretion
is TTSS dependent by detecting activity
in both bacteria and supernatant after
TTSS induction. Next, the authors created
an AvrPphB mutant lacking the prodo-
main and found that the protease is found
active only in the bacteria and is no longer
found in the secreted medium, demon-138 Chemistry & Biology 20, February 21, 201strating that the prodomain is necessary
for AvrPphB translocation (Figure 1B).
Lastly, they designed an AvrPphB with
a mutation in the prodomain cleavage
site and found that while the protein is still
able to bind to the ABP FH11 and
undergoes secretion into the medium, it
is no longer able to activate HR in the
host plant cell. Taken together, these
results surprisingly show that the prodo-
main is necessary for translocation of
the protease through the pilus, and its
removal is required to trigger plant cell
hypersensitivity.
In contrast to fluorogenic substrate
probes that undergo cleavage and pro-
duce a fluorescent signal in the sur-
rounding area, covalently binding ABPs
provide the important advantage of
specifically attaching to the protease.
This feature allows for accurate and
precise analysis of the protein’s location
and the identification of the protease
responsible for the cleavage. The applica-
tion of ABPs to fundamental biological
questions enhances analytical capabil-
ities and dramatically advances our
understanding of the dynamic involved
in protease regulation. Lu et al. (2013)
successfully merge the design of a novel
ABP with a challenging biological system
and, in doing so, create an outstanding3 ª2013 Elsevier Ltd All rights reservedexample for the connection of chemical
application and biological research. Fur-
ther research should make use of this
interdisciplinary model in hopes of
advancing our understanding of the com-
plexity of protease regulation in bacterial
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In this issue of Chemistry & Biology, Dalli and colleagues report the chemical structures of resolvin D3 (RvD3)
and aspirin-triggered RvD3, derived from the u3-fatty acid docosahexaenoic acid. These compounds have
a specific temporal appearance within inflammation resolution and display anti-inflammatory and
proresolving properties. Together, the results will help design new resolvin mimetics, potential resolution
agonists with anti-inflammatory properties.Acute inflammation is the host’s response
to injury and brings together an army
of immune cells in a tightly controlled,
time- and context-dependent manner to
combat the intruders. In addition to direct
engulfment and killing of the enemy, thesecells will release a plethora of factors
that will further drive and coordinate the
inflammatory response and prepare the
tissue for subsequent repair. Among
these factors are lipid mediators, in
particular the eicosanoids, typified byprostaglandins, thromboxane, and leuko-
trienes (LTs) (Samuelsson, 1983). If the
acute inflammation does not resolve
properly, it may develop into a persistent
state, i.e., chronic inflammation, a hall-
mark of many endemic diseases such as
